nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—ABCB1—kidney cancer	0.197	1	CbGaD
Promethazine—ABCB1—Temsirolimus—kidney cancer	0.0486	0.109	CbGbCtD
Promethazine—CYP2D6—Temsirolimus—kidney cancer	0.0458	0.103	CbGbCtD
Promethazine—CYP2B6—Sorafenib—kidney cancer	0.0289	0.0649	CbGbCtD
Promethazine—CYP2C9—Capecitabine—kidney cancer	0.0274	0.0616	CbGbCtD
Promethazine—ABCB1—Pazopanib—kidney cancer	0.0255	0.0573	CbGbCtD
Promethazine—CYP2D6—Pazopanib—kidney cancer	0.024	0.054	CbGbCtD
Promethazine—ABCB1—Dactinomycin—kidney cancer	0.0233	0.0525	CbGbCtD
Promethazine—ABCB1—Gemcitabine—kidney cancer	0.0184	0.0415	CbGbCtD
Promethazine—ABCB1—Erlotinib—kidney cancer	0.0182	0.0409	CbGbCtD
Promethazine—CYP2B6—Doxorubicin—kidney cancer	0.0175	0.0394	CbGbCtD
Promethazine—CYP2C9—Paclitaxel—kidney cancer	0.0172	0.0386	CbGbCtD
Promethazine—CYP2D6—Erlotinib—kidney cancer	0.0172	0.0386	CbGbCtD
Promethazine—ABCB1—Paclitaxel—kidney cancer	0.0167	0.0375	CbGbCtD
Promethazine—CYP2C9—Sorafenib—kidney cancer	0.0153	0.0343	CbGbCtD
Promethazine—ABCB1—Sorafenib—kidney cancer	0.0148	0.0333	CbGbCtD
Promethazine—ABCB1—Vinblastine—kidney cancer	0.0146	0.0329	CbGbCtD
Promethazine—ABCB1—Vincristine—kidney cancer	0.0144	0.0323	CbGbCtD
Promethazine—CYP2D6—Sorafenib—kidney cancer	0.0139	0.0314	CbGbCtD
Promethazine—CYP2D6—Vinblastine—kidney cancer	0.0138	0.031	CbGbCtD
Promethazine—CHRM3—ureter—kidney cancer	0.0122	0.276	CbGeAlD
Promethazine—ABCB1—Sunitinib—kidney cancer	0.012	0.027	CbGbCtD
Promethazine—ABCB1—Doxorubicin—kidney cancer	0.00898	0.0202	CbGbCtD
Promethazine—CYP2D6—Doxorubicin—kidney cancer	0.00846	0.019	CbGbCtD
Promethazine—CYP2C9—urine—kidney cancer	0.00286	0.0646	CbGeAlD
Promethazine—HTR2A—urine—kidney cancer	0.00236	0.0532	CbGeAlD
Promethazine—CYP2D6—urine—kidney cancer	0.00215	0.0485	CbGeAlD
Promethazine—CALM3—nephron tubule—kidney cancer	0.00133	0.0301	CbGeAlD
Promethazine—CALM3—cortex of kidney—kidney cancer	0.00114	0.0257	CbGeAlD
Promethazine—Dimetacrine—ACHE—kidney cancer	0.0011	0.312	CrCbGaD
Promethazine—CALM3—cardiac atrium—kidney cancer	0.00108	0.0245	CbGeAlD
Promethazine—CALM2—nephron tubule—kidney cancer	0.00105	0.0236	CbGeAlD
Promethazine—CALM1—nephron tubule—kidney cancer	0.00104	0.0235	CbGeAlD
Promethazine—CHRM3—renal system—kidney cancer	0.000972	0.0219	CbGeAlD
Promethazine—CALM2—renal system—kidney cancer	0.000951	0.0215	CbGeAlD
Promethazine—CALM1—renal system—kidney cancer	0.000947	0.0214	CbGeAlD
Promethazine—CHRM3—kidney—kidney cancer	0.000939	0.0212	CbGeAlD
Promethazine—CALM2—kidney—kidney cancer	0.000919	0.0208	CbGeAlD
Promethazine—CALM1—kidney—kidney cancer	0.000915	0.0207	CbGeAlD
Promethazine—CALM2—cortex of kidney—kidney cancer	0.000895	0.0202	CbGeAlD
Promethazine—ADRA1A—renal system—kidney cancer	0.000892	0.0201	CbGeAlD
Promethazine—CALM1—cortex of kidney—kidney cancer	0.000891	0.0201	CbGeAlD
Promethazine—CALM2—gonad—kidney cancer	0.000853	0.0193	CbGeAlD
Promethazine—CALM2—cardiac atrium—kidney cancer	0.000852	0.0192	CbGeAlD
Promethazine—CALM1—gonad—kidney cancer	0.000849	0.0192	CbGeAlD
Promethazine—CALM1—cardiac atrium—kidney cancer	0.000848	0.0191	CbGeAlD
Promethazine—CYP2B6—nephron tubule—kidney cancer	0.000778	0.0176	CbGeAlD
Promethazine—CYP2B6—renal system—kidney cancer	0.000707	0.016	CbGeAlD
Promethazine—CYP2B6—kidney—kidney cancer	0.000683	0.0154	CbGeAlD
Promethazine—CYP2B6—gonad—kidney cancer	0.000634	0.0143	CbGeAlD
Promethazine—HTR2A—renal system—kidney cancer	0.000577	0.013	CbGeAlD
Promethazine—HTR2A—kidney—kidney cancer	0.000557	0.0126	CbGeAlD
Promethazine—CYP2D6—renal system—kidney cancer	0.000525	0.0119	CbGeAlD
Promethazine—HTR2A—gonad—kidney cancer	0.000517	0.0117	CbGeAlD
Promethazine—CYP2D6—kidney—kidney cancer	0.000508	0.0115	CbGeAlD
Promethazine—ABCB1—nephron tubule—kidney cancer	0.000416	0.00939	CbGeAlD
Promethazine—Ethopropazine—BCHE—kidney cancer	0.000383	0.109	CrCbGaD
Promethazine—ABCB1—renal system—kidney cancer	0.000378	0.00853	CbGeAlD
Promethazine—Insomnia—Erlotinib—kidney cancer	0.000373	0.00231	CcSEcCtD
Promethazine—Decreased appetite—Vinblastine—kidney cancer	0.000373	0.00231	CcSEcCtD
Promethazine—Decreased appetite—Everolimus—kidney cancer	0.000371	0.0023	CcSEcCtD
Promethazine—Anaphylactic shock—Sorafenib—kidney cancer	0.000371	0.0023	CcSEcCtD
Promethazine—Leukopenia—Dactinomycin—kidney cancer	0.000371	0.0023	CcSEcCtD
Promethazine—Diarrhoea—Pazopanib—kidney cancer	0.00037	0.0023	CcSEcCtD
Promethazine—Fatigue—Everolimus—kidney cancer	0.000368	0.00229	CcSEcCtD
Promethazine—Constipation—Vinblastine—kidney cancer	0.000367	0.00228	CcSEcCtD
Promethazine—Pain—Vinblastine—kidney cancer	0.000367	0.00228	CcSEcCtD
Promethazine—Constipation—Everolimus—kidney cancer	0.000365	0.00227	CcSEcCtD
Promethazine—Pain—Everolimus—kidney cancer	0.000365	0.00227	CcSEcCtD
Promethazine—ABCB1—kidney—kidney cancer	0.000365	0.00825	CbGeAlD
Promethazine—Shock—Sorafenib—kidney cancer	0.000365	0.00226	CcSEcCtD
Promethazine—Dry mouth—Sunitinib—kidney cancer	0.000364	0.00226	CcSEcCtD
Promethazine—Thrombocytopenia—Sorafenib—kidney cancer	0.000363	0.00225	CcSEcCtD
Promethazine—Dyspepsia—Erlotinib—kidney cancer	0.000363	0.00225	CcSEcCtD
Promethazine—Rash—Temsirolimus—kidney cancer	0.000362	0.00225	CcSEcCtD
Promethazine—Coordination abnormal—Doxorubicin—kidney cancer	0.000362	0.00225	CcSEcCtD
Promethazine—Dermatitis—Temsirolimus—kidney cancer	0.000362	0.00225	CcSEcCtD
Promethazine—Arrhythmia—Gemcitabine—kidney cancer	0.00036	0.00223	CcSEcCtD
Promethazine—Headache—Temsirolimus—kidney cancer	0.00036	0.00223	CcSEcCtD
Promethazine—Decreased appetite—Erlotinib—kidney cancer	0.000358	0.00222	CcSEcCtD
Promethazine—Dizziness—Pazopanib—kidney cancer	0.000358	0.00222	CcSEcCtD
Promethazine—Oedema—Sunitinib—kidney cancer	0.000357	0.00221	CcSEcCtD
Promethazine—ABCB1—cortex of kidney—kidney cancer	0.000356	0.00803	CbGeAlD
Promethazine—Fatigue—Erlotinib—kidney cancer	0.000355	0.00221	CcSEcCtD
Promethazine—Feeling abnormal—Vinblastine—kidney cancer	0.000353	0.00219	CcSEcCtD
Promethazine—Injection site reaction—Doxorubicin—kidney cancer	0.000353	0.00219	CcSEcCtD
Promethazine—Pain—Erlotinib—kidney cancer	0.000353	0.00219	CcSEcCtD
Promethazine—Constipation—Erlotinib—kidney cancer	0.000353	0.00219	CcSEcCtD
Promethazine—Feeling abnormal—Everolimus—kidney cancer	0.000352	0.00218	CcSEcCtD
Promethazine—Dermatitis contact—Doxorubicin—kidney cancer	0.000351	0.00218	CcSEcCtD
Promethazine—Shock—Sunitinib—kidney cancer	0.000351	0.00218	CcSEcCtD
Promethazine—Erythema—Gemcitabine—kidney cancer	0.000351	0.00218	CcSEcCtD
Promethazine—Thrombocytopenia—Sunitinib—kidney cancer	0.000349	0.00217	CcSEcCtD
Promethazine—Asthma—Capecitabine—kidney cancer	0.000346	0.00215	CcSEcCtD
Promethazine—Bradycardia—Paclitaxel—kidney cancer	0.000344	0.00213	CcSEcCtD
Promethazine—Rash—Pazopanib—kidney cancer	0.000341	0.00212	CcSEcCtD
Promethazine—Dermatitis—Pazopanib—kidney cancer	0.000341	0.00212	CcSEcCtD
Promethazine—Agitation—Vincristine—kidney cancer	0.00034	0.00211	CcSEcCtD
Promethazine—Headache—Pazopanib—kidney cancer	0.000339	0.0021	CcSEcCtD
Promethazine—ABCB1—gonad—kidney cancer	0.000339	0.00765	CbGeAlD
Promethazine—Oedema—Dactinomycin—kidney cancer	0.000338	0.0021	CcSEcCtD
Promethazine—Aplastic anaemia—Doxorubicin—kidney cancer	0.000334	0.00207	CcSEcCtD
Promethazine—Leukopenia—Vincristine—kidney cancer	0.000331	0.00205	CcSEcCtD
Promethazine—Thrombocytopenia—Dactinomycin—kidney cancer	0.000331	0.00205	CcSEcCtD
Promethazine—Dyspepsia—Sorafenib—kidney cancer	0.000326	0.00203	CcSEcCtD
Promethazine—Coma—Doxorubicin—kidney cancer	0.000325	0.00202	CcSEcCtD
Promethazine—Insomnia—Sunitinib—kidney cancer	0.000323	0.002	CcSEcCtD
Promethazine—Decreased appetite—Sorafenib—kidney cancer	0.000322	0.002	CcSEcCtD
Promethazine—Clomipramine—GSTP1—kidney cancer	0.000321	0.0914	CrCbGaD
Promethazine—Convulsion—Vincristine—kidney cancer	0.00032	0.00199	CcSEcCtD
Promethazine—Fatigue—Sorafenib—kidney cancer	0.00032	0.00198	CcSEcCtD
Promethazine—Pain—Sorafenib—kidney cancer	0.000317	0.00197	CcSEcCtD
Promethazine—Constipation—Sorafenib—kidney cancer	0.000317	0.00197	CcSEcCtD
Promethazine—Photosensitivity reaction—Capecitabine—kidney cancer	0.000316	0.00196	CcSEcCtD
Promethazine—Tinnitus—Paclitaxel—kidney cancer	0.000315	0.00195	CcSEcCtD
Promethazine—Dyspepsia—Sunitinib—kidney cancer	0.000314	0.00195	CcSEcCtD
Promethazine—Leukopenia—Gemcitabine—kidney cancer	0.000314	0.00195	CcSEcCtD
Promethazine—Triflupromazine—BCHE—kidney cancer	0.000314	0.0892	CrCbGaD
Promethazine—Decreased appetite—Sunitinib—kidney cancer	0.00031	0.00192	CcSEcCtD
Promethazine—Asthenia—Vinblastine—kidney cancer	0.000308	0.00191	CcSEcCtD
Promethazine—Fatigue—Sunitinib—kidney cancer	0.000308	0.00191	CcSEcCtD
Promethazine—Depression—Capecitabine—kidney cancer	0.000308	0.00191	CcSEcCtD
Promethazine—Asthenia—Everolimus—kidney cancer	0.000307	0.0019	CcSEcCtD
Promethazine—Constipation—Sunitinib—kidney cancer	0.000305	0.00189	CcSEcCtD
Promethazine—Pain—Sunitinib—kidney cancer	0.000305	0.00189	CcSEcCtD
Promethazine—Pruritus—Everolimus—kidney cancer	0.000302	0.00188	CcSEcCtD
Promethazine—Oedema—Vincristine—kidney cancer	0.000302	0.00187	CcSEcCtD
Promethazine—Anaphylactic shock—Vincristine—kidney cancer	0.000302	0.00187	CcSEcCtD
Promethazine—Arrhythmia—Paclitaxel—kidney cancer	0.000301	0.00187	CcSEcCtD
Promethazine—Jaundice—Capecitabine—kidney cancer	0.000301	0.00187	CcSEcCtD
Promethazine—Phlebitis—Doxorubicin—kidney cancer	0.0003	0.00186	CcSEcCtD
Promethazine—Thrombophlebitis—Doxorubicin—kidney cancer	0.000298	0.00185	CcSEcCtD
Promethazine—Asthenia—Erlotinib—kidney cancer	0.000296	0.00184	CcSEcCtD
Promethazine—Thrombocytopenia—Vincristine—kidney cancer	0.000296	0.00183	CcSEcCtD
Promethazine—Photosensitivity—Doxorubicin—kidney cancer	0.000294	0.00182	CcSEcCtD
Promethazine—Erythema—Paclitaxel—kidney cancer	0.000294	0.00182	CcSEcCtD
Promethazine—Decreased appetite—Dactinomycin—kidney cancer	0.000294	0.00182	CcSEcCtD
Promethazine—Diarrhoea—Vinblastine—kidney cancer	0.000293	0.00182	CcSEcCtD
Promethazine—Diarrhoea—Everolimus—kidney cancer	0.000292	0.00181	CcSEcCtD
Promethazine—Pruritus—Erlotinib—kidney cancer	0.000292	0.00181	CcSEcCtD
Promethazine—Fatigue—Dactinomycin—kidney cancer	0.000291	0.00181	CcSEcCtD
Promethazine—Pain—Dactinomycin—kidney cancer	0.000289	0.00179	CcSEcCtD
Promethazine—Tension—Paclitaxel—kidney cancer	0.000288	0.00179	CcSEcCtD
Promethazine—Agranulocytosis—Capecitabine—kidney cancer	0.000288	0.00179	CcSEcCtD
Promethazine—Oedema—Gemcitabine—kidney cancer	0.000286	0.00178	CcSEcCtD
Promethazine—Anaphylactic shock—Gemcitabine—kidney cancer	0.000286	0.00178	CcSEcCtD
Promethazine—Nervousness—Paclitaxel—kidney cancer	0.000285	0.00177	CcSEcCtD
Promethazine—Dizziness—Vinblastine—kidney cancer	0.000284	0.00176	CcSEcCtD
Promethazine—Dizziness—Everolimus—kidney cancer	0.000283	0.00175	CcSEcCtD
Promethazine—Muscle spasms—Paclitaxel—kidney cancer	0.000282	0.00175	CcSEcCtD
Promethazine—Diarrhoea—Erlotinib—kidney cancer	0.000282	0.00175	CcSEcCtD
Promethazine—Hypotension—Vincristine—kidney cancer	0.000282	0.00175	CcSEcCtD
Promethazine—Bradycardia—Capecitabine—kidney cancer	0.000282	0.00175	CcSEcCtD
Promethazine—Thrombocytopenia—Gemcitabine—kidney cancer	0.00028	0.00174	CcSEcCtD
Promethazine—Feeling abnormal—Dactinomycin—kidney cancer	0.000278	0.00173	CcSEcCtD
Promethazine—Vision blurred—Paclitaxel—kidney cancer	0.000277	0.00172	CcSEcCtD
Promethazine—Tremor—Paclitaxel—kidney cancer	0.000275	0.00171	CcSEcCtD
Promethazine—Insomnia—Vincristine—kidney cancer	0.000273	0.00169	CcSEcCtD
Promethazine—Dizziness—Erlotinib—kidney cancer	0.000273	0.00169	CcSEcCtD
Promethazine—Agitation—Paclitaxel—kidney cancer	0.00027	0.00168	CcSEcCtD
Promethazine—Rash—Everolimus—kidney cancer	0.000269	0.00167	CcSEcCtD
Promethazine—Dermatitis—Everolimus—kidney cancer	0.000269	0.00167	CcSEcCtD
Promethazine—Headache—Vinblastine—kidney cancer	0.000269	0.00167	CcSEcCtD
Promethazine—Headache—Everolimus—kidney cancer	0.000268	0.00166	CcSEcCtD
Promethazine—Hypotension—Gemcitabine—kidney cancer	0.000268	0.00166	CcSEcCtD
Promethazine—Asthenia—Sorafenib—kidney cancer	0.000266	0.00165	CcSEcCtD
Promethazine—Syncope—Paclitaxel—kidney cancer	0.000263	0.00163	CcSEcCtD
Promethazine—Leukopenia—Paclitaxel—kidney cancer	0.000263	0.00163	CcSEcCtD
Promethazine—Decreased appetite—Vincristine—kidney cancer	0.000262	0.00163	CcSEcCtD
Promethazine—Pruritus—Sorafenib—kidney cancer	0.000262	0.00163	CcSEcCtD
Promethazine—Fatigue—Vincristine—kidney cancer	0.00026	0.00161	CcSEcCtD
Promethazine—Rash—Erlotinib—kidney cancer	0.00026	0.00161	CcSEcCtD
Promethazine—Dermatitis—Erlotinib—kidney cancer	0.00026	0.00161	CcSEcCtD
Promethazine—Palpitations—Paclitaxel—kidney cancer	0.00026	0.00161	CcSEcCtD
Promethazine—Insomnia—Gemcitabine—kidney cancer	0.000259	0.00161	CcSEcCtD
Promethazine—Headache—Erlotinib—kidney cancer	0.000258	0.0016	CcSEcCtD
Promethazine—Tinnitus—Capecitabine—kidney cancer	0.000258	0.0016	CcSEcCtD
Promethazine—Loss of consciousness—Paclitaxel—kidney cancer	0.000258	0.0016	CcSEcCtD
Promethazine—Constipation—Vincristine—kidney cancer	0.000258	0.0016	CcSEcCtD
Promethazine—Pain—Vincristine—kidney cancer	0.000258	0.0016	CcSEcCtD
Promethazine—Diplopia—Doxorubicin—kidney cancer	0.000258	0.0016	CcSEcCtD
Promethazine—Asthenia—Sunitinib—kidney cancer	0.000256	0.00159	CcSEcCtD
Promethazine—Somnolence—Gemcitabine—kidney cancer	0.000255	0.00158	CcSEcCtD
Promethazine—Convulsion—Paclitaxel—kidney cancer	0.000255	0.00158	CcSEcCtD
Promethazine—Diarrhoea—Sorafenib—kidney cancer	0.000254	0.00157	CcSEcCtD
Promethazine—Pruritus—Sunitinib—kidney cancer	0.000252	0.00157	CcSEcCtD
Promethazine—Anxiety—Paclitaxel—kidney cancer	0.000249	0.00155	CcSEcCtD
Promethazine—Decreased appetite—Gemcitabine—kidney cancer	0.000249	0.00154	CcSEcCtD
Promethazine—Arrhythmia—Capecitabine—kidney cancer	0.000247	0.00153	CcSEcCtD
Promethazine—Fatigue—Gemcitabine—kidney cancer	0.000247	0.00153	CcSEcCtD
Promethazine—Dizziness—Sorafenib—kidney cancer	0.000245	0.00152	CcSEcCtD
Promethazine—Pain—Gemcitabine—kidney cancer	0.000245	0.00152	CcSEcCtD
Promethazine—Constipation—Gemcitabine—kidney cancer	0.000245	0.00152	CcSEcCtD
Promethazine—Dry mouth—Paclitaxel—kidney cancer	0.000245	0.00152	CcSEcCtD
Promethazine—Diarrhoea—Sunitinib—kidney cancer	0.000244	0.00152	CcSEcCtD
Promethazine—Asthenia—Dactinomycin—kidney cancer	0.000242	0.0015	CcSEcCtD
Promethazine—Confusional state—Paclitaxel—kidney cancer	0.000242	0.0015	CcSEcCtD
Promethazine—Erythema—Capecitabine—kidney cancer	0.000241	0.0015	CcSEcCtD
Promethazine—Oedema—Paclitaxel—kidney cancer	0.00024	0.00149	CcSEcCtD
Promethazine—Anaphylactic shock—Paclitaxel—kidney cancer	0.00024	0.00149	CcSEcCtD
Promethazine—Dizziness—Sunitinib—kidney cancer	0.000236	0.00146	CcSEcCtD
Promethazine—Feeling abnormal—Gemcitabine—kidney cancer	0.000236	0.00146	CcSEcCtD
Promethazine—Shock—Paclitaxel—kidney cancer	0.000236	0.00146	CcSEcCtD
Promethazine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000235	0.00146	CcSEcCtD
Promethazine—Tachycardia—Paclitaxel—kidney cancer	0.000234	0.00145	CcSEcCtD
Promethazine—Rash—Sorafenib—kidney cancer	0.000234	0.00145	CcSEcCtD
Promethazine—Dermatitis—Sorafenib—kidney cancer	0.000234	0.00145	CcSEcCtD
Promethazine—Headache—Sorafenib—kidney cancer	0.000232	0.00144	CcSEcCtD
Promethazine—Muscle spasms—Capecitabine—kidney cancer	0.000232	0.00144	CcSEcCtD
Promethazine—Diarrhoea—Dactinomycin—kidney cancer	0.000231	0.00143	CcSEcCtD
Promethazine—Vision blurred—Capecitabine—kidney cancer	0.000227	0.00141	CcSEcCtD
Promethazine—Tremor—Capecitabine—kidney cancer	0.000226	0.0014	CcSEcCtD
Promethazine—Rash—Sunitinib—kidney cancer	0.000225	0.0014	CcSEcCtD
Promethazine—Dermatitis—Sunitinib—kidney cancer	0.000225	0.00139	CcSEcCtD
Promethazine—Hypotension—Paclitaxel—kidney cancer	0.000224	0.00139	CcSEcCtD
Promethazine—Headache—Sunitinib—kidney cancer	0.000224	0.00139	CcSEcCtD
Promethazine—Asthma—Doxorubicin—kidney cancer	0.000223	0.00138	CcSEcCtD
Promethazine—Insomnia—Paclitaxel—kidney cancer	0.000217	0.00135	CcSEcCtD
Promethazine—Asthenia—Vincristine—kidney cancer	0.000217	0.00134	CcSEcCtD
Promethazine—Syncope—Capecitabine—kidney cancer	0.000216	0.00134	CcSEcCtD
Promethazine—Leukopenia—Capecitabine—kidney cancer	0.000216	0.00134	CcSEcCtD
Promethazine—Somnolence—Paclitaxel—kidney cancer	0.000213	0.00132	CcSEcCtD
Promethazine—Palpitations—Capecitabine—kidney cancer	0.000213	0.00132	CcSEcCtD
Promethazine—Rash—Dactinomycin—kidney cancer	0.000213	0.00132	CcSEcCtD
Promethazine—Loss of consciousness—Capecitabine—kidney cancer	0.000212	0.00131	CcSEcCtD
Promethazine—Dyspepsia—Paclitaxel—kidney cancer	0.000211	0.00131	CcSEcCtD
Promethazine—Decreased appetite—Paclitaxel—kidney cancer	0.000208	0.00129	CcSEcCtD
Promethazine—Fatigue—Paclitaxel—kidney cancer	0.000207	0.00128	CcSEcCtD
Promethazine—Diarrhoea—Vincristine—kidney cancer	0.000207	0.00128	CcSEcCtD
Promethazine—Asthenia—Gemcitabine—kidney cancer	0.000205	0.00127	CcSEcCtD
Promethazine—Constipation—Paclitaxel—kidney cancer	0.000205	0.00127	CcSEcCtD
Promethazine—Pain—Paclitaxel—kidney cancer	0.000205	0.00127	CcSEcCtD
Promethazine—Anxiety—Capecitabine—kidney cancer	0.000205	0.00127	CcSEcCtD
Promethazine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000204	0.00126	CcSEcCtD
Promethazine—Pruritus—Gemcitabine—kidney cancer	0.000203	0.00126	CcSEcCtD
Promethazine—Dry mouth—Capecitabine—kidney cancer	0.000201	0.00125	CcSEcCtD
Promethazine—Dizziness—Vincristine—kidney cancer	0.0002	0.00124	CcSEcCtD
Promethazine—Drowsiness—Doxorubicin—kidney cancer	0.000199	0.00123	CcSEcCtD
Promethazine—Confusional state—Capecitabine—kidney cancer	0.000198	0.00123	CcSEcCtD
Promethazine—Feeling abnormal—Paclitaxel—kidney cancer	0.000198	0.00123	CcSEcCtD
Promethazine—Oedema—Capecitabine—kidney cancer	0.000197	0.00122	CcSEcCtD
Promethazine—Diarrhoea—Gemcitabine—kidney cancer	0.000196	0.00122	CcSEcCtD
Promethazine—Jaundice—Doxorubicin—kidney cancer	0.000194	0.0012	CcSEcCtD
Promethazine—Shock—Capecitabine—kidney cancer	0.000194	0.0012	CcSEcCtD
Promethazine—Thrombocytopenia—Capecitabine—kidney cancer	0.000193	0.0012	CcSEcCtD
Promethazine—Tachycardia—Capecitabine—kidney cancer	0.000192	0.00119	CcSEcCtD
Promethazine—Rash—Vincristine—kidney cancer	0.00019	0.00118	CcSEcCtD
Promethazine—Dermatitis—Vincristine—kidney cancer	0.00019	0.00118	CcSEcCtD
Promethazine—Headache—Vincristine—kidney cancer	0.000189	0.00117	CcSEcCtD
Promethazine—Agranulocytosis—Doxorubicin—kidney cancer	0.000186	0.00115	CcSEcCtD
Promethazine—Hypotension—Capecitabine—kidney cancer	0.000184	0.00114	CcSEcCtD
Promethazine—Bradycardia—Doxorubicin—kidney cancer	0.000182	0.00113	CcSEcCtD
Promethazine—Rash—Gemcitabine—kidney cancer	0.000181	0.00112	CcSEcCtD
Promethazine—Dermatitis—Gemcitabine—kidney cancer	0.00018	0.00112	CcSEcCtD
Promethazine—Headache—Gemcitabine—kidney cancer	0.000179	0.00111	CcSEcCtD
Promethazine—Insomnia—Capecitabine—kidney cancer	0.000178	0.0011	CcSEcCtD
Promethazine—Dyspepsia—Capecitabine—kidney cancer	0.000173	0.00107	CcSEcCtD
Promethazine—Asthenia—Paclitaxel—kidney cancer	0.000172	0.00107	CcSEcCtD
Promethazine—Decreased appetite—Capecitabine—kidney cancer	0.000171	0.00106	CcSEcCtD
Promethazine—Fatigue—Capecitabine—kidney cancer	0.00017	0.00105	CcSEcCtD
Promethazine—Pruritus—Paclitaxel—kidney cancer	0.00017	0.00105	CcSEcCtD
Promethazine—Constipation—Capecitabine—kidney cancer	0.000168	0.00104	CcSEcCtD
Promethazine—Pain—Capecitabine—kidney cancer	0.000168	0.00104	CcSEcCtD
Promethazine—Tinnitus—Doxorubicin—kidney cancer	0.000166	0.00103	CcSEcCtD
Promethazine—Diarrhoea—Paclitaxel—kidney cancer	0.000164	0.00102	CcSEcCtD
Promethazine—Feeling abnormal—Capecitabine—kidney cancer	0.000162	0.00101	CcSEcCtD
Promethazine—Diphenhydramine—PTGS1—kidney cancer	0.000161	0.0457	CrCbGaD
Promethazine—Arrhythmia—Doxorubicin—kidney cancer	0.000159	0.000989	CcSEcCtD
Promethazine—Dizziness—Paclitaxel—kidney cancer	0.000159	0.000984	CcSEcCtD
Promethazine—Erythema—Doxorubicin—kidney cancer	0.000155	0.000964	CcSEcCtD
Promethazine—Tension—Doxorubicin—kidney cancer	0.000152	0.000946	CcSEcCtD
Promethazine—Chlorpromazine—BCHE—kidney cancer	0.000151	0.043	CrCbGaD
Promethazine—Rash—Paclitaxel—kidney cancer	0.000151	0.000938	CcSEcCtD
Promethazine—Dermatitis—Paclitaxel—kidney cancer	0.000151	0.000937	CcSEcCtD
Promethazine—Nervousness—Doxorubicin—kidney cancer	0.000151	0.000936	CcSEcCtD
Promethazine—Headache—Paclitaxel—kidney cancer	0.00015	0.000932	CcSEcCtD
Promethazine—Muscle spasms—Doxorubicin—kidney cancer	0.000149	0.000927	CcSEcCtD
Promethazine—Vision blurred—Doxorubicin—kidney cancer	0.000146	0.000909	CcSEcCtD
Promethazine—Agitation—Doxorubicin—kidney cancer	0.000143	0.000886	CcSEcCtD
Promethazine—Asthenia—Capecitabine—kidney cancer	0.000141	0.000876	CcSEcCtD
Promethazine—Syncope—Doxorubicin—kidney cancer	0.000139	0.000865	CcSEcCtD
Promethazine—Pruritus—Capecitabine—kidney cancer	0.000139	0.000864	CcSEcCtD
Promethazine—Leukopenia—Doxorubicin—kidney cancer	0.000139	0.000863	CcSEcCtD
Promethazine—Diltiazem—ABCB1—kidney cancer	0.000138	0.0392	CrCbGaD
Promethazine—Palpitations—Doxorubicin—kidney cancer	0.000137	0.000852	CcSEcCtD
Promethazine—Loss of consciousness—Doxorubicin—kidney cancer	0.000137	0.000847	CcSEcCtD
Promethazine—Convulsion—Doxorubicin—kidney cancer	0.000135	0.000835	CcSEcCtD
Promethazine—Diarrhoea—Capecitabine—kidney cancer	0.000135	0.000835	CcSEcCtD
Promethazine—Anxiety—Doxorubicin—kidney cancer	0.000132	0.000818	CcSEcCtD
Promethazine—Dizziness—Capecitabine—kidney cancer	0.00013	0.000807	CcSEcCtD
Promethazine—Dry mouth—Doxorubicin—kidney cancer	0.000129	0.000803	CcSEcCtD
Promethazine—Confusional state—Doxorubicin—kidney cancer	0.000128	0.000793	CcSEcCtD
Promethazine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000127	0.000787	CcSEcCtD
Promethazine—Oedema—Doxorubicin—kidney cancer	0.000127	0.000787	CcSEcCtD
Promethazine—Shock—Doxorubicin—kidney cancer	0.000125	0.000774	CcSEcCtD
Promethazine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000124	0.00077	CcSEcCtD
Promethazine—Rash—Capecitabine—kidney cancer	0.000124	0.00077	CcSEcCtD
Promethazine—Dermatitis—Capecitabine—kidney cancer	0.000124	0.000769	CcSEcCtD
Promethazine—Tachycardia—Doxorubicin—kidney cancer	0.000124	0.000768	CcSEcCtD
Promethazine—Headache—Capecitabine—kidney cancer	0.000123	0.000765	CcSEcCtD
Promethazine—Triflupromazine—ABCB1—kidney cancer	0.000123	0.035	CrCbGaD
Promethazine—Hypotension—Doxorubicin—kidney cancer	0.000119	0.000735	CcSEcCtD
Promethazine—Insomnia—Doxorubicin—kidney cancer	0.000115	0.000712	CcSEcCtD
Promethazine—Somnolence—Doxorubicin—kidney cancer	0.000113	0.0007	CcSEcCtD
Promethazine—Dyspepsia—Doxorubicin—kidney cancer	0.000112	0.000693	CcSEcCtD
Promethazine—Decreased appetite—Doxorubicin—kidney cancer	0.00011	0.000684	CcSEcCtD
Promethazine—Fatigue—Doxorubicin—kidney cancer	0.000109	0.000678	CcSEcCtD
Promethazine—Constipation—Doxorubicin—kidney cancer	0.000108	0.000673	CcSEcCtD
Promethazine—Pain—Doxorubicin—kidney cancer	0.000108	0.000673	CcSEcCtD
Promethazine—Feeling abnormal—Doxorubicin—kidney cancer	0.000105	0.000648	CcSEcCtD
Promethazine—Carbamazepine—ABCB1—kidney cancer	0.000103	0.0292	CrCbGaD
Promethazine—Asthenia—Doxorubicin—kidney cancer	9.1e-05	0.000565	CcSEcCtD
Promethazine—Pruritus—Doxorubicin—kidney cancer	8.97e-05	0.000557	CcSEcCtD
Promethazine—Diarrhoea—Doxorubicin—kidney cancer	8.68e-05	0.000538	CcSEcCtD
Promethazine—Clomipramine—ABCB1—kidney cancer	8.64e-05	0.0246	CrCbGaD
Promethazine—Chlorprothixene—ABCB1—kidney cancer	8.6e-05	0.0245	CrCbGaD
Promethazine—Dizziness—Doxorubicin—kidney cancer	8.39e-05	0.00052	CcSEcCtD
Promethazine—Rash—Doxorubicin—kidney cancer	8e-05	0.000496	CcSEcCtD
Promethazine—Dermatitis—Doxorubicin—kidney cancer	7.99e-05	0.000496	CcSEcCtD
Promethazine—Trimipramine—ABCB1—kidney cancer	7.95e-05	0.0226	CrCbGaD
Promethazine—Headache—Doxorubicin—kidney cancer	7.94e-05	0.000493	CcSEcCtD
Promethazine—Doxepin—ABCB1—kidney cancer	7.58e-05	0.0216	CrCbGaD
Promethazine—Trifluoperazine—ABCB1—kidney cancer	7.55e-05	0.0215	CrCbGaD
Promethazine—Methadone—ABCB1—kidney cancer	7.54e-05	0.0214	CrCbGaD
Promethazine—Desipramine—ABCB1—kidney cancer	6.95e-05	0.0198	CrCbGaD
Promethazine—Chlorpromazine—ABCB1—kidney cancer	5.93e-05	0.0169	CrCbGaD
Promethazine—Imipramine—ABCB1—kidney cancer	5.9e-05	0.0168	CrCbGaD
Promethazine—Amitriptyline—ABCB1—kidney cancer	5.86e-05	0.0167	CrCbGaD
Promethazine—CHRM3—Signaling by GPCR—PIK3CA—kidney cancer	5.17e-06	3.47e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—RAF1—kidney cancer	5.17e-06	3.47e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—RELA—kidney cancer	5.16e-06	3.46e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—RAF1—kidney cancer	5.15e-06	3.45e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—BRAF—kidney cancer	5.15e-06	3.45e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—RELA—kidney cancer	5.14e-06	3.45e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—CTNNB1—kidney cancer	5.14e-06	3.45e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—CTNNB1—kidney cancer	5.14e-06	3.45e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MTOR—kidney cancer	5.14e-06	3.45e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—RAF1—kidney cancer	5.13e-06	3.44e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MYC—kidney cancer	5.13e-06	3.44e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—RELA—kidney cancer	5.13e-06	3.44e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	5.12e-06	3.44e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	5.12e-06	3.44e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—ERBB2—kidney cancer	5.11e-06	3.43e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—RELA—kidney cancer	5.11e-06	3.43e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—kidney cancer	5.11e-06	3.43e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—PIK3CA—kidney cancer	5.11e-06	3.43e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—ERBB2—kidney cancer	5.1e-06	3.42e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—RAF1—kidney cancer	5.08e-06	3.41e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—ERBB2—kidney cancer	5.08e-06	3.41e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—MAPK3—kidney cancer	5.07e-06	3.4e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—MAPK3—kidney cancer	5.07e-06	3.4e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—RAF1—kidney cancer	5.07e-06	3.4e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—RELA—kidney cancer	5.06e-06	3.39e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MTOR—kidney cancer	5.06e-06	3.39e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—RELA—kidney cancer	5.05e-06	3.39e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MTOR—kidney cancer	5.05e-06	3.38e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—POMC—kidney cancer	5.04e-06	3.38e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—POMC—kidney cancer	5.04e-06	3.38e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	5.03e-06	3.37e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MTOR—kidney cancer	5.03e-06	3.37e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MAPK1—kidney cancer	5.02e-06	3.36e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—ERBB2—kidney cancer	5.02e-06	3.36e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MTOR—kidney cancer	5.01e-06	3.36e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PTEN—kidney cancer	5.01e-06	3.36e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PTEN—kidney cancer	5.01e-06	3.36e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—MAPK1—kidney cancer	4.99e-06	3.35e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—BRAF—kidney cancer	4.98e-06	3.34e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—BRAF—kidney cancer	4.98e-06	3.34e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—kidney cancer	4.97e-06	3.34e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MTOR—kidney cancer	4.96e-06	3.33e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MTOR—kidney cancer	4.95e-06	3.32e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—KRAS—kidney cancer	4.95e-06	3.32e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.86e-06	3.26e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—MAPK1—kidney cancer	4.83e-06	3.24e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—MAPK1—kidney cancer	4.83e-06	3.24e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	4.82e-06	3.23e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—kidney cancer	4.81e-06	3.23e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—kidney cancer	4.81e-06	3.23e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—MAPK3—kidney cancer	4.79e-06	3.21e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	4.74e-06	3.18e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—KRAS—kidney cancer	4.74e-06	3.18e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CDKN1B—kidney cancer	4.73e-06	3.17e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—POMC—kidney cancer	4.73e-06	3.17e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CDKN1B—kidney cancer	4.72e-06	3.16e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL2—kidney cancer	4.72e-06	3.16e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—KRAS—kidney cancer	4.71e-06	3.16e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CDKN1B—kidney cancer	4.7e-06	3.15e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	4.66e-06	3.12e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CDKN1B—kidney cancer	4.65e-06	3.12e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL2—kidney cancer	4.64e-06	3.11e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—MAPK3—kidney cancer	4.64e-06	3.11e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—MAPK3—kidney cancer	4.64e-06	3.11e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL2—kidney cancer	4.63e-06	3.11e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL2—kidney cancer	4.62e-06	3.1e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL2—kidney cancer	4.6e-06	3.09e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCND1—kidney cancer	4.6e-06	3.08e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—JUN—kidney cancer	4.59e-06	3.08e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—MAPK1—kidney cancer	4.56e-06	3.06e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—KRAS—kidney cancer	4.56e-06	3.06e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—KRAS—kidney cancer	4.56e-06	3.06e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL2—kidney cancer	4.56e-06	3.06e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	4.56e-06	3.05e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL2—kidney cancer	4.55e-06	3.05e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—PIK3CA—kidney cancer	4.55e-06	3.05e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCND1—kidney cancer	4.53e-06	3.04e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—JUN—kidney cancer	4.52e-06	3.03e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCND1—kidney cancer	4.52e-06	3.03e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—JUN—kidney cancer	4.51e-06	3.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCND1—kidney cancer	4.5e-06	3.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—JUN—kidney cancer	4.49e-06	3.01e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCND1—kidney cancer	4.49e-06	3.01e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	4.48e-06	3.01e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—JUN—kidney cancer	4.48e-06	3e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CTNNB1—kidney cancer	4.47e-06	3e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CTNNB1—kidney cancer	4.46e-06	2.99e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTEN—kidney cancer	4.46e-06	2.99e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—POMC—kidney cancer	4.45e-06	2.99e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCND1—kidney cancer	4.44e-06	2.98e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CTNNB1—kidney cancer	4.44e-06	2.98e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTEN—kidney cancer	4.44e-06	2.98e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—JUN—kidney cancer	4.43e-06	2.97e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCND1—kidney cancer	4.43e-06	2.97e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MAPK3—kidney cancer	4.43e-06	2.97e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—JUN—kidney cancer	4.42e-06	2.97e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—POMC—kidney cancer	4.41e-06	2.96e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—MAPK1—kidney cancer	4.41e-06	2.96e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—MAPK1—kidney cancer	4.41e-06	2.96e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	4.4e-06	2.95e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—kidney cancer	4.4e-06	2.95e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CTNNB1—kidney cancer	4.39e-06	2.94e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTEN—kidney cancer	4.37e-06	2.93e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTEN—kidney cancer	4.36e-06	2.92e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PIK3CA—kidney cancer	4.35e-06	2.92e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTEN—kidney cancer	4.35e-06	2.91e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTEN—kidney cancer	4.34e-06	2.91e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTEN—kidney cancer	4.33e-06	2.9e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PIK3CA—kidney cancer	4.33e-06	2.9e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—KRAS—kidney cancer	4.31e-06	2.89e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MYC—kidney cancer	4.3e-06	2.89e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—RAF1—kidney cancer	4.3e-06	2.88e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTEN—kidney cancer	4.29e-06	2.88e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK3—kidney cancer	4.28e-06	2.87e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK3—kidney cancer	4.28e-06	2.87e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—RELA—kidney cancer	4.28e-06	2.87e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTEN—kidney cancer	4.28e-06	2.87e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—ERBB2—kidney cancer	4.25e-06	2.85e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—kidney cancer	4.21e-06	2.82e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MAPK1—kidney cancer	4.21e-06	2.82e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MTOR—kidney cancer	4.2e-06	2.81e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—kidney cancer	4.2e-06	2.81e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTEN—kidney cancer	4.2e-06	2.81e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PIK3CA—kidney cancer	4.19e-06	2.81e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PIK3CA—kidney cancer	4.19e-06	2.81e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—KRAS—kidney cancer	4.17e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—KRAS—kidney cancer	4.17e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MYC—kidney cancer	4.16e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MYC—kidney cancer	4.16e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RAF1—kidney cancer	4.16e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RAF1—kidney cancer	4.16e-06	2.79e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—RELA—kidney cancer	4.14e-06	2.78e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—RELA—kidney cancer	4.14e-06	2.78e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—ERBB2—kidney cancer	4.11e-06	2.76e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—ERBB2—kidney cancer	4.11e-06	2.76e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK1—kidney cancer	4.07e-06	2.73e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK1—kidney cancer	4.07e-06	2.73e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MTOR—kidney cancer	4.06e-06	2.72e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MTOR—kidney cancer	4.06e-06	2.72e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—kidney cancer	4.01e-06	2.69e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—KRAS—kidney cancer	3.98e-06	2.67e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—kidney cancer	3.96e-06	2.65e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	3.95e-06	2.65e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CDKN1B—kidney cancer	3.94e-06	2.64e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—kidney cancer	3.94e-06	2.64e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—kidney cancer	3.92e-06	2.63e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—kidney cancer	3.91e-06	2.62e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	3.87e-06	2.6e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—kidney cancer	3.86e-06	2.59e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—kidney cancer	3.85e-06	2.58e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—KRAS—kidney cancer	3.85e-06	2.58e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—KRAS—kidney cancer	3.85e-06	2.58e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—kidney cancer	3.83e-06	2.57e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—kidney cancer	3.83e-06	2.57e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CDKN1B—kidney cancer	3.81e-06	2.55e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CDKN1B—kidney cancer	3.81e-06	2.55e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK3—kidney cancer	3.79e-06	2.54e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—kidney cancer	3.77e-06	2.53e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—kidney cancer	3.76e-06	2.52e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—JUN—kidney cancer	3.75e-06	2.51e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.73e-06	2.5e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—kidney cancer	3.73e-06	2.5e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—kidney cancer	3.73e-06	2.5e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK3—kidney cancer	3.72e-06	2.5e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CTNNB1—kidney cancer	3.72e-06	2.5e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK3—kidney cancer	3.71e-06	2.49e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK3—kidney cancer	3.7e-06	2.48e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MYC—kidney cancer	3.69e-06	2.47e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	3.67e-06	2.46e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK3—kidney cancer	3.66e-06	2.45e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—kidney cancer	3.65e-06	2.45e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—kidney cancer	3.65e-06	2.45e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—kidney cancer	3.63e-06	2.44e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—kidney cancer	3.63e-06	2.44e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.63e-06	2.43e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—JUN—kidney cancer	3.63e-06	2.43e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—JUN—kidney cancer	3.63e-06	2.43e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—kidney cancer	3.63e-06	2.43e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MYC—kidney cancer	3.62e-06	2.43e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MYC—kidney cancer	3.61e-06	2.42e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK1—kidney cancer	3.61e-06	2.42e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MYC—kidney cancer	3.6e-06	2.41e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CTNNB1—kidney cancer	3.6e-06	2.41e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CTNNB1—kidney cancer	3.6e-06	2.41e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MYC—kidney cancer	3.56e-06	2.39e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MYC—kidney cancer	3.56e-06	2.38e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3.55e-06	2.38e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.55e-06	2.38e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK1—kidney cancer	3.54e-06	2.38e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—kidney cancer	3.53e-06	2.37e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—kidney cancer	3.53e-06	2.37e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK1—kidney cancer	3.53e-06	2.37e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK1—kidney cancer	3.52e-06	2.36e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—kidney cancer	3.52e-06	2.36e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—kidney cancer	3.51e-06	2.35e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—kidney cancer	3.51e-06	2.35e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	3.49e-06	2.34e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK1—kidney cancer	3.48e-06	2.33e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—KRAS—kidney cancer	3.41e-06	2.29e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—KRAS—kidney cancer	3.35e-06	2.25e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—KRAS—kidney cancer	3.35e-06	2.24e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—KRAS—kidney cancer	3.34e-06	2.24e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—KRAS—kidney cancer	3.33e-06	2.23e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—KRAS—kidney cancer	3.29e-06	2.21e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—kidney cancer	3.29e-06	2.2e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—KRAS—kidney cancer	3.28e-06	2.2e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—kidney cancer	3.28e-06	2.2e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—kidney cancer	3.17e-06	2.12e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—kidney cancer	3.17e-06	2.12e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—kidney cancer	3.14e-06	2.11e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	3.13e-06	2.1e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK3—kidney cancer	3.1e-06	2.08e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—kidney cancer	3.1e-06	2.08e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	3.08e-06	2.07e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—kidney cancer	3.08e-06	2.06e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—kidney cancer	3.07e-06	2.06e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—kidney cancer	3.07e-06	2.06e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—kidney cancer	3.06e-06	2.05e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—kidney cancer	3.06e-06	2.05e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—kidney cancer	3.03e-06	2.03e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	3.03e-06	2.03e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—kidney cancer	3.02e-06	2.02e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MYC—kidney cancer	3.01e-06	2.02e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK3—kidney cancer	3e-06	2.01e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK3—kidney cancer	3e-06	2.01e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—kidney cancer	2.98e-06	2e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—kidney cancer	2.98e-06	2e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—kidney cancer	2.97e-06	1.99e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—kidney cancer	2.96e-06	1.98e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—kidney cancer	2.96e-06	1.98e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—kidney cancer	2.96e-06	1.98e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK1—kidney cancer	2.95e-06	1.98e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—kidney cancer	2.93e-06	1.96e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—kidney cancer	2.92e-06	1.96e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MYC—kidney cancer	2.92e-06	1.96e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MYC—kidney cancer	2.92e-06	1.96e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK1—kidney cancer	2.85e-06	1.91e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK1—kidney cancer	2.85e-06	1.91e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—KRAS—kidney cancer	2.78e-06	1.87e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—KRAS—kidney cancer	2.69e-06	1.81e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—KRAS—kidney cancer	2.69e-06	1.81e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—kidney cancer	2.56e-06	1.72e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—kidney cancer	2.48e-06	1.66e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—kidney cancer	2.47e-06	1.66e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—kidney cancer	2.47e-06	1.66e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—kidney cancer	2.39e-06	1.61e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—kidney cancer	2.39e-06	1.61e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—kidney cancer	2.32e-06	1.56e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.19e-06	1.47e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—kidney cancer	2.17e-06	1.45e-05	CbGpPWpGaD
